Search
for
Sort by
Research 30 of 128
- 1616 Cross-comparison of inflammatory skin disease transcriptomics identifies PTEN as a pathogenic disease classifier in cutaneous lupus erythematosus
- The influence of interferon on healthy and diseased skin
- Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics
- INTERFERONS IN DERMATOLOGY
- Plasmacytoid dendritic cells in alopecia areata: missing link?
- Interferon in the treatment of cutaneous T-cell lymphoma
- Type 1 interferon signature in the scalp lesions of alopecia areata
- Breakdown of Immune Tolerance in AIRE-Deficient Rats Induces a Severe Autoimmune Polyendocrinopathy–Candidiasis–Ectodermal Dystrophy–like Autoimmune Disease
- Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects
- Case Report: Diffuse Hypertrichosis in the Course of Hepatitis C Treatment by IFN-<i>α</i> and Ribavirin
- CUTANEOUS T-CELL LYMPHOMA
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Reply to ‘CD123 immunohistochemistry for plasmacytoid dendritic cells is useful in the diagnosis of scarring alopecia’: three PDC-related parameters are useful in differentiating lupus alopecia from LPP
- Partial regrowth of scalp hair in a patient treated with extracorporeal pholtochemotherapy and interferon ? 2a
- Effect of diode pumping solid state laser with wavelength 589 nm on gene expression of interlukine-2 and interferon-gamma Lowercase in human T-lymphocytes
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Mechanisms regulating skin immunity and inflammation
- Skin wound healing in humans and mice: Challenges in translational research
- Drug-Induced Hair Loss and Hair Growth
- Drug-Induced Skin, Nail and Hair Disorders
- Cutaneous reactions to recombinant cytokine therapy
- What causes hidradenitis suppurativa ?—15 years after
- The role of lymphocytes in the development and treatment of alopecia areata
- Autoimmunity and autoimmune co-morbidities in psoriasis
- Telogen Effluvium due to Recombinant Interferon α-2b
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Teriflunomide in multiple sclerosis: an update
- Non-invasive Approaches for the Diagnosis of Autoimmune/Autoinflammatory Skin Diseases—A Focus on Psoriasis and Lupus erythematosus
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- Co-loading of finasteride and baicalin in phospholipid vesicles tailored for the treatment of hair disorders